Immuno-Biological Laboratories Co., Ltd.
Immuno-Biological Laboratories Co., Ltd.
Acción · JP3921300004 (XTKS)
Resumen
Sin cotización
Precio de cierre XTKS 27.10.2025: 478,00 JPY
27.10.2025 05:27
Cotizaciones actuales de Immuno-Biological Laboratories Co., Ltd.
BolsaTickerMonedaÚltima operaciónPrecioVariación diaria
XTKS: Tokyo
Tokyo
4570.T
JPY
27.10.2025 05:27
478,00 JPY
-4,00 JPY
-0,83 %
Flotación y Liquidez de las Acciones
Flotación Libre 78,66 %
Acciones en Flotación 7,33 M
Acciones en Circulación 9,31 M
Perfil de la empresa para Immuno-Biological Laboratories Co., Ltd. Acción
Immuno-Biological Laboratories Co., Ltd. engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide. The company offers ELILSA, an assay kit to quantitatively measure targeted substances; and support research services on Alzheimer's disease, metabolic syndrome, and cancer, as well as customized services for production of customized antibodies and development of ELISA systems. It also provides LipoSEARCH, a customized services for profiling and analyzing of lipoprotein through gel-filtration high performance liquid chromatography method that can profile various clinical samples, such as tiny plasma or serum samples from both small animals and human beings for broad range of research fields including lipid metabolism, development of drugs for life-style related diseases, development of functional supplemental foods, and clinical studies. In addition, the company offers LipoTEST, a support tool for diagnostic and health checks at animal clinics; and customized biomarker testing services for Life-style related diseases. Further, it operates protein production business using transgenic silkworms for manufacturing of antibodies for research reagents and diagnostic products; human collagen for cosmetic materials; development of proteins for use in drugs; and other proteins production. The company was incorporated in 1982 and is headquartered in Fujioka, Japan.
Obtén información actualizada de finAgent sobre Immuno-Biological Laboratories Co., Ltd.

Datos de la empresa

Nombre Immuno-Biological Laboratories Co., Ltd.
Empresa Immuno-Biological Laboratories Co., Ltd.
Sitio web https://www.ibl-japan.co.jp
Mercado principal XTKS Tokyo
ISIN JP3921300004
Tipo de valor Acción
Sector Healthcare
Industria Biotechnology
CEO Tsutomu Seito
Capitalización de mercado 5 Mrd.
País Japón
Moneda JPY
Empleados 0,1 T
Dirección Fujioka Laboratory, 375-0005 Fujioka
Fecha de OPV 2007-08-15

Símbolos de cotización

Nombre Símbolo
Tokyo 4570.T
Otras acciones
Los inversores que tienen Immuno-Biological Laboratories Co., Ltd. también tienen las siguientes acciones en su cartera:
DEKA FESTZINS ANL 20/27
DEKA FESTZINS ANL 20/27 Bono
MARIFIL MINES LTD
MARIFIL MINES LTD Acción
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras. Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Aviso legal Protección de datos Blog Comunidad Comentarios Changelog
Im App Store herunterladen Bei Google Play herunterladen
Todos los derechos reservados © LCP GmbH 2025